RAPT Therapeutics, Inc.RAPTNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-134.90M
↓ 89% below average
Average (7y)
$-71.47M
Historical baseline
Range
High:$-27.95M
Low:$-134.90M
CAGR
+25.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-134.90M | -7.2% |
| 2023 | $-125.85M | -48.5% |
| 2022 | $-84.75M | -24.2% |
| 2021 | $-68.21M | -30.9% |
| 2020 | $-52.09M | -23.1% |
| 2019 | $-42.30M | -18.5% |
| 2018 | $-35.71M | -27.8% |
| 2017 | $-27.95M | - |